Arvaya Healthcare (BOM:524723) Beneish M-Score: 27.51 (As of Jul. 01, 2026)


BOM:524723 Arvaya Healthcare Ltd BOM:524723
34 GF Score
Price ₹67.11
GF Value ₹48.97
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Arvaya Healthcare Beneish M-Score?

Arvaya Healthcare BOM:524723 34 Beneish M-Score is 27.51 as of Jul. 01, 2026. GuruFocus rates BOM:524723 with a GF Score™ of 34/100 and a GF Value™ of ₹48.97 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 112 Medical Distribution companies, Arvaya Healthcare ranks worse than 100% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score 27.51 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for Arvaya Healthcare's Beneish M-Score or its related term are showing as below:

BOM:524723' s Beneish M-Score Range Over the Past 10 Years
Min: -2.84   Med: -2.01   Max: 27.51
Current: 27.51

During the past 13 years, the highest Beneish M-Score of Arvaya Healthcare was 27.51. The lowest was -2.84. And the median was -2.01.


Arvaya Healthcare Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Arvaya Healthcare's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arvaya Healthcare Beneish M-Score Chart

Arvaya Healthcare Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.84 -2.81 -2.15 -1.57 27.51

Arvaya Healthcare Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.57 0.00 0.00 0.00 27.51

BOM:524723 vs MCK, CAH, COR: Beneish M-Score Comparison

For the Medical Distribution subindustry, Arvaya Healthcare's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arvaya Healthcare Beneish M-Score vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Arvaya Healthcare's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Arvaya Healthcare's Beneish M-Score falls into.


BOM:524723
34GF Score
Arvaya Healthcare Ltd BOM:524723
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Arvaya Healthcare Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Arvaya Healthcare for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.522+0.528 * 0.4202+0.404 * 1.6309+0.892 * 32.6759+0.115 * 104.4823
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0+4.679 * 0.028288-0.327 * 31.505
=27.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was ₹37.66 Mil.
Revenue was ₹91.13 Mil.
Gross Profit was ₹46.58 Mil.
Total Current Assets was ₹381.06 Mil.
Total Assets was ₹1,406.24 Mil.
Property, Plant and Equipment(Net PPE) was ₹637.04 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹6.16 Mil.
Selling, General, & Admin. Expense(SGA) was ₹0.00 Mil.
Total Current Liabilities was ₹326.69 Mil.
Long-Term Debt & Capital Lease Obligation was ₹434.85 Mil.
Net Income was ₹7.02 Mil.
Gross Profit was ₹0.00 Mil.
Cash Flow from Operations was ₹-32.76 Mil.
Total Receivables was ₹2.21 Mil.
Revenue was ₹2.79 Mil.
Gross Profit was ₹0.60 Mil.
Total Current Assets was ₹29.82 Mil.
Total Assets was ₹35.90 Mil.
Property, Plant and Equipment(Net PPE) was ₹0.00 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹0.24 Mil.
Selling, General, & Admin. Expense(SGA) was ₹1.01 Mil.
Total Current Liabilities was ₹0.62 Mil.
Long-Term Debt & Capital Lease Obligation was ₹0.00 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(37.664 / 91.133) / (2.208 / 2.789)
=0.413286 / 0.791682
=0.522

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(0.599 / 2.789) / (46.581 / 91.133)
=0.214772 / 0.511132
=0.4202

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (381.061 + 637.041) / 1406.24) / (1 - (29.821 + 0) / 35.896)
=0.276011 / 0.169239
=1.6309

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=91.133 / 2.789
=32.6759

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0.244 / (0.244 + 0)) / (6.156 / (6.156 + 637.041))
=1 / 0.009571
=104.4823

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(0 / 91.133) / (1.014 / 2.789)
=0 / 0.363571
=0

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((434.846 + 326.688) / 1406.24) / ((0 + 0.617) / 35.896)
=0.541539 / 0.017189
=31.505

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(7.024 - 0 - -32.756) / 1406.24
=0.028288

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Arvaya Healthcare has a M-score of 27.51 signals that the company is likely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of 27.51 mean?
Arvaya Healthcare (BOM:524723) has a Beneish M-Score of 27.51 as of Jul. 01, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Arvaya Healthcare and its competitors. According to the industry distribution chart, Arvaya Healthcare ranks #112 out of 112 companies in the Medical Distribution industry.
Is Arvaya Healthcare's Beneish M-Score too high?
Arvaya Healthcare's current Beneish M-Score is 27.51. Based on the distribution chart, Arvaya Healthcare ranks #112 out of 112 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Arvaya Healthcare has a GF Score™ of 34/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Arvaya Healthcare's Beneish M-Score compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Arvaya Healthcare ranks #112 out of 112 companies for Beneish M-Score. This places Arvaya Healthcare in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Distribution company?
A good Beneish M-Score depends on the Medical Distribution industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Arvaya Healthcare and its competitors. Arvaya Healthcare's current Beneish M-Score is 27.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arvaya Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Arvaya Healthcare (BOM:524723) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹48.97, compared to a current price of ₹67.11 — trading 37% above its estimated fair value. The current Beneish M-Score is 27.51. Arvaya Healthcare's overall GF Score™ is 34/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Arvaya Healthcare (BOM:524723), the current Beneish M-Score is 27.51 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Arvaya Healthcare (BOM:524723) Overvalued in 2026?

Based on GuruFocus' analysis, Arvaya Healthcare stock appears to be overvalued. The current stock price of ₹67.11 is trading 37% above its estimated GF Value™ of ₹48.97. GuruFocus considers Arvaya Healthcare to be Significantly Overvalued.

Key valuation signals for BOM:524723:

  • Beneish M-Score: 27.51
  • GF Value™: ₹48.97 vs. price of ₹67.11 (37% above fair value)
  • GF Score™: 34/100 with 7 warning signs

No single metric tells the full story. See the BOM:524723 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Arvaya Healthcare Business Description

Address G S Road, Nirvana Co Working spaces, Mezzanine Floor, Itag Plaza, ABC, Kamrup, Dispur, Gmc, Guwahati, AS, IND, 781005
Arvaya Healthcare Ltd is focused on developing an integrated healthcare platform in India that combines hospital services, diagnostics, wellness services, and digital health management solutions. Its operations include multi-specialty hospitals, a digital health platform for appointment booking and health record management, diagnostic services including laboratory testing and home sample collection, and wellness facilities offering preventive and recovery-focused programs.
34GF Score

Get the complete analysis for BOM:524723

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹67.11
Price
₹48.97
GF Value